ArticleCureus2025
The Effect of Implementing Advanced Strategies to Improve Immunization Coverage in the Elogbele Health Area.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVaccination is a key component of primary healthcare, preventing millions of deaths each year. Therefore, this study aims to explore the impact of advanced vaccination strategies on enhancing immunization coverage in the Elogbele health area from January to May 2023.
methodsWe conducted this retrospective study in the Elogbele health area in the Edea health district, Littoral, Cameroon. We extracted the variables for the number of vaccinated children from the vaccination and tally registers of the area's health facilities and analyzed them using Microsoft Excel 2016 (Microsoft Corporation, Redmond, USA).
resultsThe activities carried out in the area led to a clear improvement in the number of vaccinated children with Bacille Calmette-Guérin (BCG) (14 vs. 15), measles rubella vaccine first dose (MR 1) (16 vs. 89), pentavalent vaccine first dose (PENTA 1) (9 vs. 103), and pentavalent vaccine third dose (PENTA 3) (13 vs. 130), as well as in their BCG (2.31% vs. 2.47%), MR 1 (2.82% vs. 15.67%), PENTA 1 (1.58% vs. 18.13%), and PENTA 3 (2.29% vs. 22.89%) vaccination coverage.
conclusionThis study has demonstrated the importance of implementing advanced strategies and enabled health workers in the Elogbele health area to strengthen their immunization capabilities, improve immunization coverage, and catch up with the number of unimmunized children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.